Titan Pharmaceuticals (OTCBB: TTNP) is a biomedical pharmaceutical company most known for its flagship drug, Probuphine, used to treat opioid addiction. Probuphine has proved …
In a research report released today, Roth Capital analyst Scott Henry initiated coverage on shares of Titan Pharmaceuticals (OTC:TTNP) with a $1.25 price target, which represents …
